Anzeige
Mehr »
Login
Dienstag, 27.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
Setzt jetzt der Dollar-Regen ein? Die Transformation zur sprudelnden Gold-Quelle!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18:42Boston Scientific tops expectations with 53% sales growth over 2020
17:42Signifier hypes up eXcite tongue stimulation device for sleep apnea with $35M series D
17:42Ex-Kiadis CBO takes the wheel at SynOx after $358M Sanofi buyout
17:42Biogen's second tau bet in Alzheimer's passes early test, though odds of success remains 'low'
16:42BD fortifies surgical mesh portfolio with acquisition of polymer maker Tepha
16:42AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push
16:42AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics
15:42Merck women's health spinout Organon bags preterm labor drug ahead of phase 3
15:42Artios raises $153M to fund DNA damage repair clinical trials
13:42IMIDomics emerges with $16.5M, former Takeda exec at the helm, and a precision approach to inflammatory disease
10:42As it preps for Wall Street, WCG still finding time for deals as it snaps up eClinical firm VeraSci
MoProthena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm
MoPhilips' CPAP recall dents second quarter connected care sales
MoPathAI branches into clinical lab services with acquisition of Poplar Healthcare
MoDenali's Hunter syndrome data fails to impress, but 'Aduhelm-lenient' FDA could still approve
MoTo turn off disease-causing genes, Talus Bio wants to knock proteins off of DNA
MoBayer's BlueRock Therapeutics adjusts leadership team with CSO promoted to CEO
MoFrom speedy review to standstill: FDA spurns Iterum's antibiotic, demands another trial
MoMedtronic begins European rollout of drug-coated balloon catheter to treat blocked arteries
MoPerkinElmer inks massive $5.25B deal for reagent producer BioLegend
MoLumira Ventures raises largest investment pot to date, nabbing $220M for life sciences bets
MoAbbvie posts new data on drug that could replace glasses or contacts for far-sightedness
MoBayer hires Ruettinger from Roche to head early cancer R&D
MoFDA demands for data from Incyte as it rejects PD-1 retifanlimab for approval
FrPassage Bio hires CMO, CFO replacements after May departures, adds chief commercial officer